Berberine No Help for Metabolic Markers in Patients With Obesity and MASLD

(MedPage Today) — Treatment with the supplement berberine failed to reduce visceral adipose tissue or liver fat in adults with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized trial from China found….

Source link : https://www.medpagetoday.com/gastroenterology/generalhepatology/119460

Author :

Publish date : 2026-01-16 16:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Berberine No Help for Metabolic Markers in Patients With Obesity and MASLD

CDC Studies Show Value of Wastewater Surveillance as Possible Funding Cut Looms

Meat may play an unexpected role in helping people reach 100

Related Posts

Mitch McConnell Hospitalized; FDA’s Heart Device Warning; OTC Ivermectin

Higher Rates of EOE, Food Allergy Mostly in White Male Teens

Model Predicts Recurrent C difficile Infection Risk in IBD

Childhood-Onset Conditions May Affect Adult Hospitalization

New Wearable Patch Detects Skin Cancer: How It Works

Can Hope Prime the Immune System via Brain Reward Pathways?

Higher Rates of EOE, Food Allergy Mostly in White Male Teens

Model Predicts Recurrent C difficile Infection Risk in IBD

Childhood-Onset Conditions May Affect Adult Hospitalization

New Wearable Patch Detects Skin Cancer: How It Works

Can Hope Prime the Immune System via Brain Reward Pathways?

CMA Funds Program to HELP International Physicians Practice

Early Antenatal Prediabetes Tied to Postpartum T2D

Revised Obesity Definition Reveals Hidden Cardiac Risk

Categories

Archives